These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Cognitive impairment in multiple sclerosis. State of research and methodological issues]. Lembach Y; Adler G Fortschr Neurol Psychiatr; 2014 May; 82(5):280-97; quiz 298. PubMed ID: 24824207 [No Abstract] [Full Text] [Related]
28. Cognitive trajectories in 4 patients with pediatric-onset multiple sclerosis: serial evaluation over a decade. Marin SE; Banwell BB; Till C J Child Neurol; 2013 Dec; 28(12):1577-86. PubMed ID: 23143723 [TBL] [Abstract][Full Text] [Related]
29. The Italian validation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) and the application of the Cognitive Impairment Index scoring procedure in MS patients. Argento O; Incerti CC; Quartuccio ME; Magistrale G; Francia A; Caltagirone C; Pisani V; Nocentini U Neurol Sci; 2018 Jul; 39(7):1237-1244. PubMed ID: 29704074 [TBL] [Abstract][Full Text] [Related]
30. Treatment options of cognitive impairment in multiple sclerosis. Patti F; Leone C; D'Amico E Neurol Sci; 2010 Nov; 31(Suppl 2):S265-9. PubMed ID: 20953811 [TBL] [Abstract][Full Text] [Related]
31. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project. Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137 [TBL] [Abstract][Full Text] [Related]
32. Cognitive Aspects in Multiple Sclerosis. Lisak M; Špiljak B; Pašić H; Trkanjec Z Psychiatr Danub; 2021 Dec; 33(Suppl 13):177-182. PubMed ID: 35150483 [TBL] [Abstract][Full Text] [Related]
33. A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients. Niccolai C; Portaccio E; Goretti B; Hakiki B; Giannini M; Pastò L; Righini I; Falautano M; Minacapelli E; Martinelli V; Incerti C; Nocentini U; Fenu G; Cocco E; Marrosu MG; Garofalo E; Ambra FI; Maddestra M; Consalvo M; Viterbo RG; Trojano M; Losignore NA; Zimatore GB; Pietrolongo E; Lugaresi A; Pippolo L; Roscio M; Ghezzi A; Castellano D; Stecchi S; Amato MP BMC Neurol; 2015 Oct; 15():204. PubMed ID: 26472052 [TBL] [Abstract][Full Text] [Related]
34. Cognitive deficits in multiple sclerosis: a systematic review. Ferreira ML Arq Neuropsiquiatr; 2010 Aug; 68(4):632-41. PubMed ID: 20730323 [TBL] [Abstract][Full Text] [Related]
35. Cognitive measures used in adults with multiple sclerosis: A systematic review. Elwick H; Topcu G; Allen CM; Drummond A; Evangelou N; Nair RD Neuropsychol Rehabil; 2022 Oct; 32(9):2464-2481. PubMed ID: 34121613 [TBL] [Abstract][Full Text] [Related]
36. Cognitive dysfunction in multiple sclerosis: the effect of pharmacological interventions. Lyros E; Messinis L; Papageorgiou SG; Papathanasopoulos P Int Rev Psychiatry; 2010; 22(1):35-42. PubMed ID: 20222786 [TBL] [Abstract][Full Text] [Related]
37. Managing cognitive impairment and its impact in multiple sclerosis: An Australian multidisciplinary perspective. Lechner-Scott J; Agland S; Allan M; Darby D; Diamond K; Merlo D; van der Walt A Mult Scler Relat Disord; 2023 Nov; 79():104952. PubMed ID: 37683558 [TBL] [Abstract][Full Text] [Related]
38. The cognitive burden of multiple sclerosis in children. Banwell BL; Anderson PE Neurology; 2005 Mar; 64(5):891-4. PubMed ID: 15753431 [TBL] [Abstract][Full Text] [Related]